Stephen F Traynelis Selected Research

Dopamine (Intropin)

1/2018	Glutamatergic Tuning of Hyperactive Striatal Projection Neurons Controls the Motor Response to Dopamine Replacement in Parkinsonian Primates.
9/2007	Exacerbation of dopaminergic terminal damage in a mouse model of Parkinson's disease by the G-protein-coupled receptor protease-activated receptor 1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stephen F Traynelis Research Topics

Disease

17	Nervous System Diseases (Neurological Disorders) 04/2024 - 07/2004
16	Epilepsy (Aura) 01/2023 - 01/2014
10	Brain Diseases (Brain Disorder) 01/2024 - 01/2014
9	Parkinson Disease (Parkinson's Disease) 01/2023 - 09/2007
8	Schizophrenia (Dementia Praecox) 01/2024 - 07/2015
6	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 11/2012
6	Neurodevelopmental Disorders 01/2024 - 10/2016
6	Intellectual Disability (Idiocy) 01/2020 - 07/2015
5	Inflammation (Inflammations) 08/2014 - 10/2007
4	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2023 - 09/2004
4	Brain Injuries (Brain Injury) 01/2023 - 09/2004
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 09/2007
3	Autistic Disorder (Autism) 01/2023 - 07/2015
3	Brain Ischemia (Cerebral Ischemia) 01/2023 - 10/2003
3	Seizures (Absence Seizure) 01/2020 - 10/2016
3	Autism Spectrum Disorder 01/2020 - 10/2016
3	Stroke (Strokes) 01/2019 - 01/2015
3	Ischemia 12/2015 - 05/2009
2	Mental Disorders (Mental Disorder) 01/2024 - 01/2017
2	Neoplasms (Cancer) 01/2023 - 10/2016
2	Rare Diseases (Rare Disease) 01/2023 - 11/2014
2	Pain (Aches) 01/2023 - 11/2012
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2019 - 10/2016
2	Neuroinflammatory Diseases 08/2014 - 05/2013
2	Gliosis 09/2007 - 04/2005
1	Fragile X Syndrome (Martin Bell Syndrome) 02/2024
1	Rett Syndrome (Rett's Disorder) 01/2024
1	Tuberous Sclerosis (Bourneville's Disease) 01/2023
1	Malformations of Cortical Development 01/2023
1	Drug Overdose 01/2023
1	Muscle Hypotonia (Hypotonia) 01/2020
1	Central Nervous System Diseases (CNS Diseases) 01/2019
1	Partial Epilepsies (Epilepsy, Partial) 07/2018
1	Aphasia (Dysphasia) 07/2018
1	Polymicrogyria 01/2018
1	Mood Disorders (Mood Disorder) 01/2017
1	Ischemic Stroke 01/2017
1	Status Epilepticus (Complex Partial Status Epilepticus) 10/2016
1	Glioma (Gliomas) 10/2016
1	Learning Disabilities (Learning Disability) 10/2016
1	Dementia (Dementias) 01/2016
1	Smith-Magenis Syndrome 11/2014
1	Sepsis (Septicemia) 08/2014
1	Neuralgia (Stump Neuralgia) 10/2010
1	Glioblastoma (Glioblastoma Multiforme) 02/2010
1	Encephalitis (Encephalitis, Rasmussen) 07/2009

Drug/Important Bio-Agent (IBA)

41	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 03/2024 - 09/2005
5	Ionotropic Glutamate ReceptorsIBA 01/2024 - 01/2017
5	N-Methylaspartate (NMDA)IBA 01/2024 - 09/2005
4	LigandsIBA 01/2018 - 01/2014
4	Serine Proteases (Serine Protease)IBA 05/2009 - 07/2004
4	Peptide Hydrolases (Proteases)FDA Link 05/2009 - 09/2004
3	Ion Channels (Ion Channel)IBA 01/2023 - 03/2014
3	Ligand-Gated Ion ChannelsIBA 10/2021 - 01/2014
3	Glutamic Acid (Glutamate)FDA Link 07/2018 - 11/2014
3	Proteinase-Activated ReceptorsIBA 05/2009 - 05/2007
2	AcidsIBA 01/2020 - 07/2015
2	Dopamine (Intropin)FDA LinkGeneric 01/2018 - 09/2007
2	2- (2- furanyl)- 7- (2- (4- (4- (2- methoxyethoxy)phenyl)- 1- piperazinyl)ethyl)- 7H- pyrazolo(4,3- e)(1,2,4)triazolo(1,5- c)pyrimidine- 5- amineIBA 01/2016 - 08/2014
2	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 01/2016 - 07/2014
2	PAR-1 ReceptorIBA 09/2007 - 10/2003
1	trans-sodium crocetinate (crocetin)IBA 01/2023
1	RGS ProteinsIBA 01/2023
1	GTP-Binding Proteins (G-Protein)IBA 01/2023
1	Analgesics (Analgesic Drugs)IBA 01/2023
1	Morphine (MS Contin)FDA LinkGeneric 01/2023
1	ParvalbuminsIBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	Opioid Analgesics (Opioids)IBA 01/2023
1	Pentylenetetrazole (Metrazol)IBA 01/2020
1	Protons (Proton)IBA 01/2019
1	Guanylate KinasesIBA 12/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	MagnesiumIBA 10/2016
1	Ketamine FDA LinkGeneric 10/2016
1	Anticonvulsants (Antiepileptic Drugs)IBA 10/2016
1	Peptides (Polypeptides)IBA 01/2016
1	Amyloid (Amyloid Fibrils)IBA 01/2016
1	GABA Receptors (GABA Receptor)IBA 07/2015
1	Kainic Acid Receptors (Kainate Receptor)IBA 07/2015
1	Cycloserine (Seromycin)FDA Link 01/2015
1	Nonsense Codon (Nonsense Mutation)IBA 11/2014
1	LipopolysaccharidesIBA 08/2014
1	Green Fluorescent ProteinsIBA 07/2014
1	Adenosine A2 Receptor AntagonistsIBA 07/2014
1	Memantine (Namenda)FDA Link 03/2014
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 05/2013
1	Caffeine (No Doz)FDA LinkGeneric 02/2010
1	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 02/2010
1	CalciumIBA 02/2010
1	Inositol (Myoinositol)IBA 02/2010
1	Inositol 1,4,5-Trisphosphate Receptors (Inositol Triphosphate Receptor)IBA 02/2010
1	Adenosine Triphosphate (ATP)IBA 07/2009
1	Adenosine (Adenocard)FDA LinkGeneric 07/2009

Therapy/Procedure

5	Therapeutics 01/2020 - 02/2010
3	Precision Medicine 10/2019 - 10/2016
1	Analgesia 01/2023
1	Electrodes (Electrode) 01/2018
1	Lasers (Laser) 08/2014
1	Laser Therapy (Surgery, Laser) 08/2014